Abstract
Adjuvants are essential components of vaccines that have been particularly effective at promoting protective humoral immunity to infectious diseases and preventing mortality and morbidity. There are many different types of adjuvants with different modes of action. A better understanding of their potential adjuvanticity could provide guidance for the development of novel adjuvants for cancer immunotherapy. In this article, we review the importance of adjuvants in vaccine development, their mechanisms of action and adjuvant-induced autoimmunity and discuss some strategies for driving the development of new vaccine adjuvants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
